Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma

July 27, 2022 | Comments Off on Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma

Frontiers in Oncology 2022 June 20 [Link] Hely Ollila, Mikko I Mäyränpää, Lassi Paavolainen, Juuso Paajanen, Katja Välimäki, Eva Sutinen, Henrik Wolff, Jari Räsänen, Olli Kallioniemi, Marjukka Myllärniemi, Ilkka Ilonen,…

Thrombocytopenia as an Immune-Related Adverse Event in Malignant Pleural Mesothelioma: A Case Report

July 26, 2022 | Comments Off on Thrombocytopenia as an Immune-Related Adverse Event in Malignant Pleural Mesothelioma: A Case Report

JTO Clinical and Research Reports 2022 June 9 [Link] Takaaki Tanaka, Shoji Asakura, Kazuya Hisamatsu, Nobukazu Fujimoto Abstract A 69-year-old man presented with a pulmonary opacity at a regular medical…

Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma/sarcomatoid pleural mesothelioma with desmoplastic features

July 25, 2022 | Comments Off on Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma/sarcomatoid pleural mesothelioma with desmoplastic features

Annals of Diagnostic Pathology 2022 June 30 [Link] Prakasit Sa-Ngiamwibool, Makoto Hamasaki, Yoshiaki Kinoshita, Shinji Matsumoto, Ayuko Sato, Tohru Tsujimura, Takahiko Kasai, Kenzo Hiroshima, Kei Kushitani, Yukio Takeshima, Kunimitsu Kawahara,…

A comprehensive study of alternative splicing in malignant pleural mesothelioma identifies potential therapeutic targets in a new cluster with poor survival

July 22, 2022 | Comments Off on A comprehensive study of alternative splicing in malignant pleural mesothelioma identifies potential therapeutic targets in a new cluster with poor survival

Thoracic Cancer 2022 July 5 [Link] Ming-Ming Shao, Xin Qiao, Qing-Yu Chen, Feng-Shuang Yi Abstract Background: Malignant pleural mesothelioma (MPM) is one of the most aggressive tumors with few effective…

Immunotherapy approaches for malignant pleural mesothelioma

July 21, 2022 | Comments Off on Immunotherapy approaches for malignant pleural mesothelioma

Nature Reviews. Clinical Oncology. 2022 July 1 [Link] Dean A Fennell, Sean Dulloo, James Harber Abstract Over the past decade, immune-checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer. In…

Prognostic factors of malignant peritoneal mesothelioma: a retrospective study of 52 female patients

July 20, 2022 | Comments Off on Prognostic factors of malignant peritoneal mesothelioma: a retrospective study of 52 female patients

World Journal of Surgical Oncology 2022 June 29 [Link]Jianting Ma, Shengzhi Zhang Abstract Background: Prognosis in malignant peritoneal mesothelioma (MPM) remains poor, and the associated factors are unclear. Therefore, this…

Rapid diagnosis of malignant pleural mesothelioma and its discrimination from lung cancer and benign exudative effusions using blood serum

July 19, 2022 | Comments Off on Rapid diagnosis of malignant pleural mesothelioma and its discrimination from lung cancer and benign exudative effusions using blood serum

Biochimica et Biophysica Acta 2022 June 23 [Link] Dilek Yonar, Mete Severcan, Rafig Gurbanov, Abdulsamet Sandal, Ulku Yilmaz, Salih Emri, Feride Severcan Abstract Malignant pleural mesothelioma (MPM), an aggressive cancer…

Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo

July 18, 2022 | Comments Off on Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo

Journal of Translational Medicine 2022 June 25 [Link] Roberto Bei, Monica Benvenuto, Chiara Focaccetti, Sara Fazi, Marta Moretti, Daniela Nardozi, Valentina Angiolini, Sara Ciuffa, Loredana Cifaldi, Raffaele Carrano, Camilla Palumbo,…

Second Surgery for Recurrent Malignant Pleural Mesothelioma after Multimodality Treatment: A Systematic Review

July 15, 2022 | Comments Off on Second Surgery for Recurrent Malignant Pleural Mesothelioma after Multimodality Treatment: A Systematic Review

Journal of Clinical Medicine 2022 June 10 [Link] Alice Bellini, Sara Mazzarra, Sara Sterrantino, Desideria Argnani, Franco Stella Abstract Malignant pleural mesothelioma (MPM) is an aggressive asbestos-related tumour with poor…

A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas

July 14, 2022 | Comments Off on A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas

Archives of Pathology & Laboratory Medicine 2022 June 23 [Link] Luka Brcic, Nolwenn Le Stang, Florian Gallob, Daniel Pissaloux, Ruth Sequeiros, Sandrine Paindavoine, Jean Claude Pairon, Marie Karanian, Sanja Dacic,…

Categories